A pet’s subtle change in behavior or appearance can often be the first sign of a developing health issue, yet these early warnings are frequently missed, leading to diagnoses only after a condition has become advanced and more difficult to treat. A Korean startup, Sibiliter, is revolutionizing this dynamic with its AI-powered health management platform, Lifet, which transforms a standard smartphone into a preliminary diagnostic device for pets. The company’s forward-thinking approach has garnered significant investor confidence, recently securing a pre-Series A bridge funding round led by Korea Technology Finance Corporation and AC Pathfinder. This latest financial injection pushed Sibiliter’s cumulative funding beyond $1.39 million, validating its mission to empower pet owners with accessible, proactive tools for monitoring their animal’s well-being directly from home and fostering a new era of preventative pet care.
The Science Behind the Snapshot
At the core of the Lifet platform is a sophisticated proprietary AI technology engineered to analyze and diagnose progressive diseases in pets within a mere three seconds, requiring nothing more than a photo taken on a smartphone. The system’s remarkable capability is best exemplified by its patella luxation diagnostic software. Through rigorous clinical trials, this specific tool achieved an outstanding 97.6% sensitivity and 98.8% specificity, showcasing a high degree of accuracy in identifying the common joint condition. This level of precision was instrumental in the software becoming Korea’s first Class 3 approved veterinary medical device, a significant regulatory achievement. The technology’s credibility was further bolstered by a publication in the esteemed scientific journal Scientific Reports, providing peer-reviewed validation of its performance. The platform’s diagnostic reach extends beyond orthopedics to include the analysis of periodontal disease, obesity, and cataracts, and has already gained significant market traction with over 170,000 cumulative analyses conducted and 80,000 registered members.
From Diagnosis to a Digital Ecosystem
Sibiliter’s commercialization strategy involved scaling its business through strategic partnerships, offering its AI health check functionality via API modules to major corporations, including smartphone manufacturers, insurance providers, and telecommunications companies. A pivotal achievement of this model was the collaboration with DB Insurance to launch “Lifet Pet Insurance,” the first policy in Korea to utilize AI analysis as a basis for determining premium discounts. This innovative product directly connected proactive health monitoring with tangible financial benefits for pet owners. The company’s leadership previously outlined a comprehensive vision for a pet homecare ecosystem that integrated its diagnostic services with personalized e-commerce for health-related products and pet insurance for medical coverage. Sibiliter’s announced roadmap also detailed an expansion of its service offerings with a primary skin disease analysis tool and included plans to showcase its technology at CES 2026. Ultimately, the company’s stated intent was to pursue an aggressive global market expansion aimed at establishing a new industry benchmark for at-home pet care.
